Can AI assist synthetic biology for new drug development?
Nathan Lanclos and Graham Hudson, Ph.D., and from the University of California, Berkeley, Keasling Lab and the Joint BioEnergy Institute (JBEI)
Leading data, scientific, and pharmaceutical experts discuss the current challenges in drug discovery and potential opportunities to improve the process.